| Autologous chondrocyte implantation in the knee: systematic review and economic evaluation H Mistry, M Connock, J Pink, D Shyangdan, C Clar, P Royle, LC Biant, ... Health Technology Assessment 21 (6), 1-294, 2017 | 268 | 2017 |
| Dabigatran etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analyses J Pink, S Lane, M Pirmohamed, DA Hughes Bmj 343, 2011 | 226 | 2011 |
| Comparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that progresses to active tuberculosis: systematic review and … P Auguste, A Tsertsvadze, J Pink, R Court, N McCarthy, P Sutcliffe, ... BMC infectious diseases 17, 1-13, 2017 | 158 | 2017 |
| Dementia: assessment, management and support: summary of updated NICE guidance J Pink, J O’Brien, L Robinson, D Longson bmj 361, 2018 | 134 | 2018 |
| Parkinson’s disease: summary of updated NICE guidance G Rogers, D Davies, J Pink, P Cooper Bmj 358, 2017 | 110 | 2017 |
| Chronic obstructive pulmonary disease: diagnosis and management: summary of updated NICE guidance NS Hopkinson, A Molyneux, J Pink, MC Harrisingh Bmj 366, 2019 | 94 | 2019 |
| Cost‐effectiveness of pharmacogenetics‐guided warfarin therapy vs. alternative anticoagulation in atrial fibrillation J Pink, M Pirmohamed, S Lane, DA Hughes Clinical Pharmacology & Therapeutics 95 (2), 199-207, 2014 | 89 | 2014 |
| Folate Augmentation of Treatment--Evaluation for Depression (FolATED): randomised trial and economic evaluation E Bedson, D Bell, D Carr, B Carter, D Hughes, A Jorgensen, H Lewis, ... Health technology assessment (Winchester, England) 18 (48), vii, 2014 | 75 | 2014 |
| Assessing the cost-effectiveness of HPV vaccination strategies for adolescent girls and boys in the UK S Datta, J Pink, GF Medley, S Petrou, S Staniszewska, M Underwood, ... BMC infectious diseases 19, 1-16, 2019 | 74 | 2019 |
| Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high … P Auguste, A Tsertsvadze, J Pink, R Court, F Seedat, T Gurung, ... Health Technology Assessment (Winchester, England) 20 (38), 1, 2016 | 54 | 2016 |
| Court, R.; McCarthy, N.; Sutcliffe, P.; Clarke, A. Comparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that … P Auguste, A Tsertsvadze, J Pink BMC Infect. Dis 17 (1), 200, 2017 | 39 | 2017 |
| Comparative effectiveness of dabigatran, rivaroxaban, apixaban, and warfarin in the management of patients with nonvalvular atrial fibrillation J Pink, M Pirmohamed, DA Hughes Clinical Pharmacology & Therapeutics 94 (2), 269-276, 2013 | 32 | 2013 |
| Comparing generic and condition-specific preference-based measures in epilepsy: EQ-5D-3L and NEWQOL-6D B Mulhern, J Pink, D Rowen, S Borghs, T Butt, D Hughes, A Marson, ... Value in Health 20 (4), 687-693, 2017 | 31 | 2017 |
| Economic and health-related quality of life outcomes of whiplash associated disorders J Pink, S Petrou, E Williamson, M Williams, SE Lamb Spine 41 (17), 1378-1386, 2016 | 31 | 2016 |
| Identifying latent tuberculosis in high-risk populations: systematic review and meta-analysis of test accuracy P Auguste, J Madan, A Tsertsvadze, N McCarthy, P Sutcliffe, ... The International Journal of Tuberculosis and Lung Disease 23 (11), 1178-1190, 2019 | 27 | 2019 |
| Psychometric properties of patient reported outcome measures (PROMs) in patients diagnosed with acute respiratory distress syndrome (ARDS) HA Shah, M Dritsaki, J Pink, S Petrou Health and Quality of Life Outcomes 14, 1-13, 2016 | 24 | 2016 |
| Mechanism-based approach to the economic evaluation of pharmaceuticals: pharmacokinetic/pharmacodynamic/pharmacoeconomic analysis of rituximab for follicular lymphoma J Pink, S Lane, DA Hughes Pharmacoeconomics 30, 413-429, 2012 | 23 | 2012 |
| First steps: study protocol for a randomized controlled trial of the effectiveness of the Group Family Nurse Partnership (gFNP) program compared to routine care in improving … J Barnes, D Aistrop, E Allen, J Barlow, D Elbourne, G Macdonald, ... Trials 14, 1-12, 2013 | 21 | 2013 |
| Cost effectiveness of HPV vaccination: a systematic review of modelling approaches J Pink, B Parker, S Petrou Pharmacoeconomics 34, 847-861, 2016 | 20 | 2016 |
| A systematic review of economic models used to assess the cost-effectiveness of strategies for identifying latent tuberculosis in high-risk groups P Auguste, A Tsertsvadze, R Court, J Pink Tuberculosis 99, 81-91, 2016 | 19 | 2016 |
